1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.Genomic Instability, Microsatellite Instability, Pathologic Processes, Pathological Conditions, Signs and SymptomsActive, not recruitingPhase 22025-06-15NCT04006262